BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27656839)

  • 1. Knockdown of PARP-1 Inhibits Proliferation and ERK Signals, Increasing Drug Sensitivity in Osteosarcoma U2OS Cells.
    Li S; Cui Z; Meng X
    Oncol Res; 2016; 24(4):279-86. PubMed ID: 27656839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells.
    Huang H; Wang L; Li M; Wang X; Zhang L
    World J Surg Oncol; 2014 Aug; 12():255. PubMed ID: 25106434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
    Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
    J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells.
    Li X; Fan S; Li L; Wang L; Fan G; Zhao Q; Li Y
    Int J Oncol; 2013 Jul; 43(1):159-68. PubMed ID: 23632777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro.
    Si H; Peng C; Li J; Wang X; Zhai L; Li X; Li J
    Int J Oncol; 2012 Apr; 40(4):1291-7. PubMed ID: 22179790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.
    Tsai HC; Huang CY; Su HL; Tang CH
    PLoS One; 2014; 9(3):e90159. PubMed ID: 24637722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics.
    Engert F; Kovac M; Baumhoer D; Nathrath M; Fulda S
    Oncotarget; 2017 Jul; 8(30):48794-48806. PubMed ID: 27447864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
    Li QC; Xu H; Wang X; Wang T; Wu J
    Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of the oncogene lncRNA NEAT1 restores the availability of
    Hu Y; Yang Q; Wang L; Wang S; Sun F; Xu D; Jiang J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
    Yuan Q; Yu H; Chen J; Song X; Sun L
    Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
    Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
    Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
    Ma K; Zhang C; Huang MY; Li WY; Hu GQ
    Oncol Rep; 2016 Jul; 36(1):90-8. PubMed ID: 27176794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of osteosarcoma cells to the proapoptotic effects of carfilzomib involves activation of mitogen activated protein kinase pathways.
    Lei L; Zhang Y; Jian Q; Lei L; Lv N; Williamson RA; Chen P; Zhang D; Hu J
    Exp Physiol; 2021 Feb; 106(2):438-449. PubMed ID: 33336554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-190b inhibits tumor cell proliferation and induces apoptosis by regulating Bcl-2 in U2OS osteosarcoma cells.
    Kang M; Xia P; Hou T; Qi Z; Liao S; Yang X
    Pharmazie; 2017 May; 72(5):279-282. PubMed ID: 29441873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
    Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
    J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anemone altaica Induces Apoptosis in Human Osteosarcoma Cells.
    Chang IC; Chiang TI; Lo C; Lai YH; Yue CH; Liu JY; Hsu LS; Lee CJ
    Am J Chin Med; 2015; 43(5):1031-42. PubMed ID: 26224029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPP8 Promotes Proliferation and Restrains Apoptosis in Osteosarcoma by Regulating p38αMAPK Pathway.
    Li T; Li N; Wang L; Li J; Zhang X
    Technol Cancer Res Treat; 2021; 20():1533033821995272. PubMed ID: 33596786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of Kv1.5 Gene Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells.
    Wu J; Chen Z; Liu Q; Zeng W; Wu X; Lin B
    Int J Mol Sci; 2015 Nov; 16(11):26914-26. PubMed ID: 26569226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
    Cheng FH; Zhao ZS; Liu WD
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
    Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
    Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.